Last reviewed · How we verify

NCT06977776: Osteoporosis

Effectiveness of a Web-Based Osteoporosis Awareness Education Program Based on the Health Belief Model Among Female University Students at Risk

Completed NA Last updated 18 May 2025
What this trial tests

NA trial testing Web-Based Osteoporosis Awareness Training Based on Health Belief Model in Osteoporosis in 90 participants. Completed in 6 April 2025.

Timeline
1 January 2024
Primary endpoint
6 March 2025
6 April 2025

Quick facts

Lead sponsorKirsehir Ahi Evran Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment90
Start date1 January 2024
Primary completion6 March 2025
Estimated completion6 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 18 Weeks to 25 Weeks, female only, with Osteoporosis or Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study Title: Evaluation of the Effectiveness of a Web-Based Osteoporosis Awareness Training Program Based on the Health Belief Model in Female University Students with Osteoporosis Risk Background: Osteoporosis is a common disease worldwide, leading to a high risk of fractures, especially in women. According to World Health Organization (WHO) criteria, osteoporosis is defined as a bone mineral density (BMD) of 2.5 standard deviations or less in young, healthy women. Osteoporosis usually progresses asymptomatically and interferes with activities of daily living, leading to high mortality and morbidity rates. Furthermore, the cost of osteoporosis is estimated at 12.2-17.9 billion dollars per year worldwide. Therefore, raising awareness and adopting a healthy lifestyle are important to reduce the risk of osteoporosis among young women. Objective: This study aims to evaluate the effectiveness of a web-based educational program based on the health belief model for female university students at risk for osteoporosis. Method: The study will be conducted with a randomized controlled design. Participants will be enrolled in a web-based training program aiming to increase their knowledge about osteoporosis risk factors, preventive health behaviors and healthy lifestyle. The effectiveness of the training program will be evaluated in terms of participants' level of knowledge about osteoporosis, health beliefs and behavioral changes. Target Population: Female university students aged 18-24 years, who are at risk of osteoporosis. Expected Outcomes: The training program is expected to result in a positive change in participants' osteoporosis knowledge, health beliefs and preventive behaviors. Furthermore, it is important to disseminate such trainings among young women as an effective strategy for osteoporosis prevention. Conclusion: This study will constitute an important step towards osteoporosis prevention by aiming to increase young women's knowledge about osteoporosis, strengthen their health beliefs and improve their healthy living habits. Proving the effectiveness of the training program will shed light on the development and implementation of similar health education programs in the future. Keywords: Osteoporosis, Health Belief Model, Education Program, Female University Students, Awareness, Preventive Health Behaviors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoporosis

Currently open trials in the same condition.

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06977776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing